Skip to content
VSY Biotechnology GmbH logo — We are proud of inspiring to see better and to move better....

VSY Biotechnology GmbH

We are proud of inspiring to see better and to move better. We inspire to live better. #weinspire

Founded 2009 Germany Istanbul, Germany 149 employees Biotechnology, Fashion +3

General Information

Company Name VSY Biotechnology GmbH
Founded Year 2009
Location Germany Istanbul, Germany
Employees 149
Industries Biotechnology, Fashion, Health Care +2
Business Model B2B
Revenue Model Product Sales, One Time Purchase, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with VSY Biotechnology GmbH. To contact VSY Biotechnology GmbH, visit vsybiotechnology.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does VSY Biotechnology GmbH compare?

A PDF of VSY Biotechnology GmbH and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting VSY Biotechnology GmbH soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Homepage Update

Significant changes detected on company website (96.2% content change).

Regulatory Approval Nov 04, 2026

VSY Biotechnology's Enova Maestro trifocal optic featuring Sinusoidal Trifocal Technology has received official regulatory approval in Japan.

AI Insight

Bounce Watch AI
18 hours ago

VSY Biotechnology has achieved a significant strategic milestone with the regulatory approval of its advanced Enova Maestro trifocal optic in Japan, marking a clear expansion into a crucial Asian market. This approval highlights the company's commitment to ophthalmic innovation and its capability to bring state-of-the-art vision correction solutions to a global patient base. The timing suggests a coordinated effort to enter and promote their premium IOL offerings in new territories.

Signal Types
Regulatory Approval Market Expansion Product Update
Strategic Labels
Market Entry Product Innovation Regulatory Milestone
Next Move: Market Launch
·
Impact: 9/10
·
Ideal For: Healthcare MedTech VCs — Growth Stage

About VSY Biotechnology GmbH

VSY Biotechnology GmbH, founded in 2009 and headquartered in Germany, leverages cutting-edge technology to manufacture innovative ophthalmology products. The company's primary focus is on enhancing vision through superior intraocular lenses (IOLs) and related products.

They specialize in advanced ophthalmology products including both monofocal and multifocal IOLs and foldable scleral fixation lenses. Their forte in product innovation is complemented by a keen dedication to customer satisfaction, which aligns with their slogan: "We are proud of inspiring to see better and to move better. We inspire to live better."

With a strong presence in industries like Biotechnology, Health Care, and Medical Devices, VSY Biotechnology is positioned well for growth. Despite the absence of recent investments, the company's focus on R&D and product quality suggests it is a worthy consideration for investors seeking opportunities in the medical device sector.

Business keywords: Ophthalmology, Intraocular Lenses, Cataract Surgery, Monofocal IOLs, Multifocal IOLs, Scleral Fixation Lens, Viscoelastics, Injector Systems, Cartridge Systems, Optic Quality, Manufacturing Efficiency, Research and Development, Premium IOLs, Innovative Products

Services & Products

Development and manufacture of premium intraocular lenses
Research and innovation in ophthalmic technologies
Showcasing IOL innovations and advancements

Target Customers

Ophthalmologists Eye clinics and hospitals Healthcare providers in vision correction Distributors in the medical device sector

No funding data available for VSY Biotechnology GmbH yet.

VSY Biotechnology GmbH Alternatives & Competitors

View All Alternatives
VSY Biotechnology GmbH vs

Over 20 years of experience dedicated to intraocular lenses manufacturing

41 employees
Health Care, Manufacturing
VSY Biotechnology GmbH vs
Norlase
Norlase Denmark

Innovative, ultra-portable, affordable ophthalmic laser devices maximize practice efficiency and imp...

Growth
75 employees
Manufacturing, Medical Devices
VSY Biotechnology GmbH vs
Contamac Ltd
Contamac Ltd United Kingdom

Contamac | World leader in contact lens and intraocular lens material technology

Late Stage
72 employees
Health Care, Manufacturing

FAQ About VSY Biotechnology GmbH

We are proud of inspiring to see better and to move better. We inspire to live better. #weinspire
VSY Biotechnology GmbH was founded in 2009.
VSY Biotechnology GmbH is headquartered in Istanbul, Germany.
VSY Biotechnology GmbH operates in Biotechnology, Fashion, Health Care, Manufacturing and Medical Devices. Its work centres on Ophthalmology, Intraocular Lenses, Cataract Surgery and Monofocal IOLs. Its customers include Ophthalmologists, Eye clinics and hospitals and Healthcare providers in vision correction.
VSY Biotechnology GmbH has a B2B business model. Its revenue comes from Product Sales, One Time Purchase and Tiered Pricing.
VSY Biotechnology GmbH has approximately 149 employees.
VSY Biotechnology GmbH offers: Development and manufacture of premium intraocular lenses, Research and innovation in ophthalmic technologies, Showcasing IOL innovations and advancements.
Top alternatives and competitors to VSY Biotechnology GmbH include Cutting Edge SAS, Norlase, Contamac Ltd, Polytech Domilens GmbH, iCare. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VSY Biotechnology GmbH and Cutting Edge SAS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for VSY Biotechnology GmbH, https://bouncewatch.com/company/vsy-biotechnology, updated 9 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout